Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Madharry who wrote (949)	6/10/2000 11:09:00 AM
From: kha vu	Read Replies (1) \| Respond to of 1298

CEGE: thestreet.com <<<http://www.thestreet.com/_yahoo/markets/nightwatch/957306.html Biotech firm Cell Genesys was up smartly at night after ending the day session 10% higher. The company uses gene therapy to treat diseases such as cancer and cardiovascular disease and reported positive results for its hemophilia therapy earlier this week. Gene therapy has been making headlines lately. It is the practice of dissecting a virus and putting therapeutic genetic material inside the virus. Those viruses are injected into the patient to ease symptoms or cure the disease. There have been technical problems and side effects with this type of therapy, including one death. But recent breakthroughs have created a buzz about the treatment. Cell Genesys was lately up 1 11/16 to 29 on 25,000 Island shares. >>>>